Your browser doesn't support javascript.
loading
Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.
Fokam, Joseph; Elat, Jean-Bosco N; Billong, Serge C; Kembou, Etienne; Nkwescheu, Armand S; Obam, Nicolas M; Essiane, André; Torimiro, Judith N; Ekanmian, Gatien K; Ndjolo, Alexis; Shiro, Koulla S; Bissek, Anne C Z-K.
Afiliação
  • Fokam J; Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management (CIRCB), Yaoundé, Cameroon; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé, Cameroon; University of Rome Tor Vergata, Department of Experimental Medicine and Surgery,
  • Elat JB; National HIV Drug Resistance Surveillance and Prevention Working Group, Ministry of Public Health, Yaoundé, Cameroon; National AIDS Control Committee, Ministry of Public Health, Yaoundé, Cameroon.
  • Billong SC; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé, Cameroon; National HIV Drug Resistance Surveillance and Prevention Working Group, Ministry of Public Health, Yaoundé, Cameroon; National AIDS Control Committee, Ministry of Public Health, Yaoundé, Cameroon.
  • Kembou E; National HIV Drug Resistance Surveillance and Prevention Working Group, Ministry of Public Health, Yaoundé, Cameroon; World Health Organization (WHO), Afro, Country Office, Yaoundé, Cameroon.
  • Nkwescheu AS; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé, Cameroon; National HIV Drug Resistance Surveillance and Prevention Working Group, Ministry of Public Health, Yaoundé, Cameroon; Division of Operational Health Research, Ministry of Public Health, Yaoundé, Cameroon.
  • Obam NM; National HIV Drug Resistance Surveillance and Prevention Working Group, Ministry of Public Health, Yaoundé, Cameroon; Division of Operational Health Research, Ministry of Public Health, Yaoundé, Cameroon.
  • Essiane A; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé, Cameroon; National HIV Drug Resistance Surveillance and Prevention Working Group, Ministry of Public Health, Yaoundé, Cameroon.
  • Torimiro JN; Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management (CIRCB), Yaoundé, Cameroon; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé, Cameroon; National HIV Drug Resistance Surveillance and Prevention Working Group, Ministry
  • Ekanmian GK; United Nations program on HIV/AIDS (UNAIDS), Yaoundé, Cameroon.
  • Ndjolo A; Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management (CIRCB), Yaoundé, Cameroon; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé, Cameroon.
  • Shiro KS; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé, Cameroon; General Secretariat, Ministry of Public Health, Yaoundé, Cameroon; Agence National de Recherche sur le SIDA et les hépatites virales (ANRS), Yaoundé, Cameroon.
  • Bissek AC; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé, Cameroon; National HIV Drug Resistance Surveillance and Prevention Working Group, Ministry of Public Health, Yaoundé, Cameroon; Division of Operational Health Research, Ministry of Public Health, Yaoundé, Cameroon.
PLoS One ; 10(6): e0129210, 2015.
Article em En | MEDLINE | ID: mdl-26083364

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Organização Mundial da Saúde / Infecções por HIV / Monitoramento de Medicamentos / Fármacos Anti-HIV / Farmacorresistência Viral Tipo de estudo: Evaluation_studies / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Organização Mundial da Saúde / Infecções por HIV / Monitoramento de Medicamentos / Fármacos Anti-HIV / Farmacorresistência Viral Tipo de estudo: Evaluation_studies / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article